Floriva Liquid
NDC Package 52796-172-50
Package Information
Floriva (cholecalciferol and sodium fluoride) liquids is a medication a combination product of vitamins and fluoride. This formulation utilizes a liquid delivery system. Marketed by Bongeo Pharmaceuticals, Inc., this product is identified by NDC 52796-172.
Identification & Billing
- RxCUI: 1596005 - vitamin D3 10 MCG (400 UNT) / sodium fluoride 0.25 MG in 1 mL Oral Solution
- RxCUI: 1596005 - cholecalciferol 0.01 MG/ML / sodium fluoride 0.55 MG/ML Oral Solution
- RxCUI: 1596005 - cholecalciferol 400 UNT/ML / sodium fluoride 0.55 MG/ML Oral Solution
- RxCUI: 1596005 - vitamin D3 0.01 MG/ML (400 UNT/ML) / sodium fluoride 0.55 MG/ML (fluoride ion 0.25 MG/ML) Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52796 - Bongeo Pharmaceuticals, Inc.
- 52796-172 - Floriva
- 52796-172-50 - 1 BOTTLE, DROPPER in 1 BOX / 50 mL in 1 BOTTLE, DROPPER
- 52796-172 - Floriva
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52796-172-50 identifies a specific commercial package of 1 bottle, dropper in 1 box / 50 ml in 1 bottle, dropper of Floriva, a human prescription drug labeled by Bongeo Pharmaceuticals, Inc.. This liquid is formulated for oral use and contains cholecalciferol; sodium fluoride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bongeo Pharmaceuticals, Inc. on October 15, 2014. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a combination product of vitamins and fluoride. It is used in children to treat or prevent deficiency due to poor diet or low levels of fluoride in drinking water and other sources. Vitamins are important building blocks of the body and help keep you in good health. Fluoride is used to prevent dental cavities.
How is this Bongeo Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52796017250. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.